Bard Eclipse IVC Filter Lawsuit Set For Second Bellwether Trial to Begin May 15
The next Bard IVC filter bellwether lawsuit will begin in May involving a claim over an Eclipse filter fracture embolism.…
«
»
The next Bard IVC filter bellwether lawsuit will begin in May involving a claim over an Eclipse filter fracture embolism.…
A woman has been rewarded $33 million in an Bard Avaulta pelvic mesh trial, and more may be coming as the jury deliberates whether to inflict punitive damages on the manufacturer.…
Plaintiffs are asking the U.S. Judicial Panel On Multidistrict Litigation to consolidate all Bard hernia mesh lawsuits before one judge for pretrial proceedings.…
The first IVC filter bellwether trial has ended in a $3.6 million verdict against Bard, over problems with a Bard G2 Vena Cava Filter that fractured inside the plaintiff’s body.…
A number of different types of hernia mesh made by various manufacturers have been associated with design defects that could cause severe and life-threatening complications after hernia surgery.…
Problems with the designs of certain inferior vena cava (IVC) filters have caused many individuals nationwide to suffer severe complications and injuries when the small devices fractured or broke inside the body.…
A lawsuit filed over complications with the Bard Ventralight ST hernia mesh indicates that the mesh is causing pain and infections for a California man, but cannot be surgically removed.…
A Bard Eclipse IVC filter lawsuit will be allowed to proceed as a potential bellwether trial on failure to warn and punitive damages claims after C.R. Bard failed to convince a federal judge to dismiss the claim.…
A Bard IVC filter bellwether trial slated for March will be divided into a liability phase and a punitive damages phase, according to a court order by the federal judge overseeing the MDL.…
Problems with hernia mesh biocompatibility have plagued the industry for decades, with the latest concerns over polypropylene and how the substance interacts with the human body. Despite years of research warning of complications, many manufacturers continue to use it.…